Implementing VIRADS score for image-guided assessment of muscle invasiveness in bladder cancer pre-TURBT: An updated meta-analysis
- Ahmad R Al-Qudimat 1,2, Doaa Sabir 1, Muna Elamin 1, Mica Ching 1, Seif B Altahtamouni 1, Kalpana Singh 1, Ibrahim A Khalil 3, Khalid Alrumaihi 3,4
- Ahmad R Al-Qudimat 1,2, Doaa Sabir 1, Muna Elamin 1
- 1Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha, Qatar.
- 2Public Health college, Health Science, Qatar University, Doha, Qatar.
- 3Department of Urology, Hamad Medical Corporation, Doha, Qatar.
- 4Department of Urology, College of Medicine, Qatar University, Doha, Qatar.
- 0Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha, Qatar.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The Vesical Imaging-Reporting and Data System (VI-RADS) shows high accuracy in distinguishing bladder cancer stages using MRI. A VI-RADS score of 3 or higher effectively identifies muscle-invasive bladder cancer (MIBC).
Area Of Science
- Uro-oncology
- Diagnostic Imaging
- Medical Malignancy Staging
Background
- Bladder urothelial carcinoma is a common urinary system malignancy.
- Accurate staging, differentiating non-muscle-invasive (NMIBC) from muscle-invasive bladder cancer (MIBC), is critical for treatment selection.
- Multiparametric MRI (mpMRI) is increasingly used for bladder cancer assessment.
Purpose Of The Study
- To systematically review and meta-analyze the diagnostic accuracy of the Vesical Imaging-Reporting and Data System (VI-RADS) scoring system.
- To evaluate the sensitivity and specificity of VI-RADS using mpMRI in differentiating NMIBC from MIBC.
- To assess the utility of VI-RADS in improving bladder cancer staging.
Main Methods
- Systematic review and meta-analysis conducted following PRISMA guidelines.
- Searched PubMed, Web of Science, Embase, and Cochrane databases up to December 2023.
- Included studies evaluating VI-RADS diagnostic accuracy for NMIBC vs. MIBC differentiation using mpMRI; calculated pooled sensitivity and specificity.
Main Results
- Included 31 studies with 3,798 bladder cancer patients.
- Pooled sensitivity and specificity for predicting MIBC with a VI-RADS cutoff score ≥3 was 89%, with moderate heterogeneity.
- Higher diagnostic accuracy observed in studies using 3.0 Tesla MRI scanners and involving multiple radiologists.
Conclusions
- The VI-RADS system demonstrates high diagnostic accuracy for differentiating NMIBC from MIBC.
- A VI-RADS cutoff score of ≥3 provides optimal sensitivity and specificity for MIBC prediction.
- Integration of VI-RADS into clinical practice can potentially reduce invasive procedures and improve treatment decisions.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

